Palvella Therapeutics, Inc. (PVLA) stock
PVLANasdaqPharmaceutical PreparationsFiscal year ends December 31
$146.58+2.23 (+1.54%)
Close on Nov 18, 2026Market cap $2.11BP/E –Yield –
Palvella Therapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Palvella Therapeutics's pe ratio was 0.7× on Jan 31, 2025.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Jan 31, 2025 | 0.7× | +0.1 |
| 2024 | Dec 31, 2024 | 0.6× | – |
See a number that looks wrong?